Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)

The University of Texas System (UT)

Status and phase: Completed; Phase 4

Conditions: Basal Cell Carcinoma

Treatments: Biological: Imiquimod and Interferon alpha

Study type: Interventional

Funder types: Other

Identifiers

NCT00581425

HSC-MS-06-0478

OSP-24412

Details and patient eligibility

About

A trial to see if BCC excluding the scalp and face can be treated successfully with a combination therapy of Intron-A and Aldara.

Enrollment: 49 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Nodular or superficial basal cell carcinoma on the skin excluding scalp or face

Exclusion criteria

• Pregnancy

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

49 participants in 1 patient group

Treated

Experimental group

Treatment:

Biological: Imiquimod and Interferon alpha